Announcements Trials
Browse Landscape

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Gastritis, Atrophic 3Colorectal Neoplasms 2Tuberculosis 1Peptic Ulcer 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Lymphatic Metastasis 1Liver Neoplasms 1Liver Cirrhosis 1Influenza, Human 1Inflammatory Bowel Diseases 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Communicable Diseases 1Barrett Esophagus 1

Interventions

Cisplatin 28Paclitaxel 19Radiotherapy 17Fluorouracil 13Drug Therapy 12camrelizumab 10toripalimab 8Carboplatin 8Radiation 7Capecitabine 7Radiotherapy, Intensity-Modulated 6sintilimab 5S 1 (combination) 5Esophagectomy 5tislelizumab 4nimotuzumab 4apatinib 4anlotinib 4Irinotecan 4Cetuximab 4Afatinib 4pembrolizumab 3durvalumab 3Vinorelbine 3Positron Emission Tomography Computed Tomography 3Oxaliplatin 3Nivolumab 3Immune Checkpoint Inhibitors 3Docetaxel 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Esophageal Squamous Cell Carcinoma × Gastroscopy × Clear all
NCT04425122 2023-02-08

The Microbiome of Oesophageal Squamous Cell Carcinoma

Chinese University of Hong Kong

Unknown
200 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Communicable Diseases, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡